EP0402373A1 - Enzymatic determination of theophylline - Google Patents
Enzymatic determination of theophyllineInfo
- Publication number
- EP0402373A1 EP0402373A1 EP19890902593 EP89902593A EP0402373A1 EP 0402373 A1 EP0402373 A1 EP 0402373A1 EP 19890902593 EP19890902593 EP 19890902593 EP 89902593 A EP89902593 A EP 89902593A EP 0402373 A1 EP0402373 A1 EP 0402373A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- theophylline
- sample
- enzyme
- signal
- test composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
Definitions
- Theophylline is a bronchodilator and respiratory stimulant used in the treatment of patients with asthmatic and allergic conditions. It is also used in the treatment of congestive heart failure and acute pulmonary edema. Benefits, as well as risks, from using this drug directly relate to its serum concentration. In order for the drug to be effective, a concentration of theophylline of about 10-20 mg/L level needs to be maintained in the blood. Theophylline levels of less than 10 mg/L are therapeutically ineffective and levels of more than 20 mg/L may be toxic to the patient. This toxicity may result in brain damage and death. Because the therapeutic advantage of the drug lies only within a narrow range of concentrations and because there is a large interpatient difference in drug elimination due to physiological differences, as well as diet or other prescribed drugs, it is important to monitor patients using this drug.
- Theophylline has been measured by gas chromatography by Shah, J Pharm Sci 63(8), 1283 (1974) and by a combination of gas chromatography and mass-selective detector by Desage, et al., J Chromat 336(2), 285 (1984). It has been measured by high-pressure liquid chromatography by Thompson, et al., J Lab Clin Med 84(4), 584 (1974) and by Naish, et al., Ann Clin Biochem 16(5), 254 (1979). Schack, et al., J Pharm 97, 283 (1949) used an ultraviolet spectrophotometric method for the determination of theophylline.
- the assay readout may be turbidimetric, nephelometric, radioactive or colorimetric depending on whether turbidity, radioactivity or color is produced. Examples of these systems are reported by Painter, et al.
- enzymes have been used in an enzyme amplification assay, U. S. Patent No. 3,817,837.
- enzymes are chemically bound to ligands and these enzyme-bound-ligand combine with receptors.
- the ligand may be a drug.
- the specific reaction of the ligand with the receptors gives the specificity to the reaction while the enzyme activity is utilized as a marker for the reaction. Therefore, the enzymes used have no enzymatic recognition of the drug.
- the use of these approaches are totally different to the presently described methodology which uses enzymes instead of antibodies or ligands for the recognition of theophylline.
- the figure shown in the drawing depicts absorbance curves for theophylline utilizing enzyme before and after contact with theophylline as further described in Example 3.
- the present invention basically consists of a system for the determination of theophylline by means of a theophylline utilizing or recognizing enzyme (or substance containing such enzyme) and optionally including the use of electron carriers.
- the determination is accomplished by measurement of a signal produced by the reaction of the enzyme with any theophylline present in the sample and converting or correlating the amount of signal generated to the amount of theophylline present in the sample.
- the term theophylline utilizing enzyme means an enzyme or substance containing an enzyme which either recognizes or utilizes theophylline to produce a signal which by itself or in conjunction with other reagents or means can be measured using visual, instrumental or other state of the art methodologies.
- the principle of the test method is based on the utilization of theophylline by an enzyme. That is, the enzyme recognizes theophylline as a substrate and changes it to a different compound or product.
- the system can be described as follows:
- the methods disclosed and claimed herein involve detecting any signal produced by contact of theophylline with the theophylline utilizing enzyme which indicates that a specific enzymatic reaction has taken place.
- the signals produced are measured in a variety of ways as described herein. This process occurs in the presence or absence of added electron carriers, either electron acceptors or electron donors. Examples of electron acceptors are oxygen, nicotinamide adenine dinucleotide (NAD), dichlorophenolindophenol (DCPIP), phenazine methosulfate (PMS), methylene blue, cytochromes, ferricyanide, etc.
- electron acceptors oxygen, nicotinamide adenine dinucleotide (NAD), dichlorophenolindophenol (DCPIP), phenazine methosulfate (PMS), methylene blue, cytochromes, ferricyanide, etc.
- Examples of electron donors are reduced nicotinamide adenine dinucleotide (NADH) , reduced nicotinamide adenine dinucleotide phosphate (NADPH) , reduced flavin adenine dinucleotide (FADH), etc.
- NADH reduced nicotinamide adenine dinucleotide
- NADPH reduced nicotinamide adenine dinucleotide phosphate
- FADH flavin adenine dinucleotide
- the process of the present invention is otherwise carried out in the usual manner for enzymatic determinations, including optimized pH and temperature ranges in which theophylline utilizing enzymes are active. Moreover, such determinations are preferably carried out in a buffered environment.
- Example 4 shows the absorbance change at 410 nm that occurs when ferricyanide changes to ferrocyanide in the presence of the theophylline enzyme T-090 as the reaction takes place. This change can also be measured by spectrophotometric or electrochemical methods, or
- Example 3 Measuring the appearance of any product associated with the enzymatic reaction of theophylline.
- the products produced in this reaction vary with the particular enzyme involved.
- a theophylline enzyme can react by oxidizing, dehydrogenating or demethylating theophylline.
- Example 5 shows the appearance and measurement of formaldehyde when the theophylline enzyme T-040 was used.
- Example 6 shows the appearance and measurement of hydrogen peroxide when the theophylline enzyme T-060 was used.
- the product formation can be further illustrated by the following reactions or processes:
- the hydrogen peroxide thus produced can be determined titrimetrically, potentiometrically, polarographically, colorimetrically as well as enzymatically.
- the enzymatic methods of measuring hydrogen peroxide are preferred since they are not only specific and reliable, but can also be combined in a simple way with the hydrogen peroxide of the above reaction to produce color.
- a peroxidase method is described in Anal Bioche 105, 389, (1980).
- T-60 Using the theophylline enzyme T-60, Example 6 demonstrates that the hydrogen peroxide formation is proportional to the concentration of theophylline in the sample.
- the rate of oxygen consumption in accordance with the above general equation can be measured, for instance, by gas chromatography and depolarization methods.
- the depolarization method utilizing oxygen electrodes (available from Yellow Spring Instruments, Yellow Spring, OH.) is well known and also described in US Patent No. 3,838,011 and in J Appl Physiol 18, 1247 (1963).
- the product 1,3 dimethyl uric acid can be measured or determined by several methods.
- Example 7 describes one in which the absorbance at 292 nm is determined using the theophylline enzyme T-090. At such a wavelength 1,3 dimethy uric acid absorbs optimally. Again, the increase in absorbance was found to be proportionate to the theophylline concentration in the sample.
- the concentration of theophylline in the sample can be determined using this reaction scheme by measuring the oxidation/reduction state of the electron acceptors used.
- Examples 4 and 8 show a test method where ferricyanide is used as an acceptor and is reduced to ferrocyanide by the theophylline enzyme T-090.
- the decrease of ferricyanide is measured by measuring the decrease in absorbance at 410 nm wavelength as ferricyanide maximally absorbs at 410 nm and ferrocyanide has no absorption at that wavelength. It was again found that the decrease in absorbance was proportionate to the concentration of theophylline in the sample.
- Example 8 another way of measuring ferrocyanide is shown.
- ferrocyanide is measured chemically by using 4,7 diphenyl-1,10 phenanthroline sulfonate by the method described by Avon, M. and Shavit N., Analy Biochem 6, 549 (1963).
- the Avon method produced color which was measured at 535 nm. The color thus produced was porportionate to the concentration of theophylline in the sample.
- Example 9 illustrates the use of another electron acceptor, ferricytochro e c.
- ferricytochrome c is reduced to ferrocytochrome c.
- the appearance of ferrocytochrome c is measured by measuring the increase in absorbance at 550 nm wavelength in the presence of the theophylline enzyme T-090. Again, the change in absorbance at 550 nm wavelength was found to be proportionate to the concentration of theophylline in the sample.
- other known electron acceptors such as nicotinamide adenine dinucleotide (NAD), 2,6-dichlorophenolindophenol (DCPIP), phenazine methosulfate (PMS), etc.
- NAD nicotinamide adenine dinucleotide
- DCPIP 2,6-dichlorophenolindophenol
- PMS phenazine methosulfate
- the measurement of the change produced by the transferring of electrons in the above reaction is by no means limited to the spectrophotometric or reflectance methods. It is well known to use potentiometric, fluorescent or electrochemical methods to measure the transfer or change of electrons in oxidation-reduction reactions. For example, Reed and Hawkredge have shown an electron transfer reaction of cytochrome c at silver elctrodes in Anal Chem 59, 2334 (1987) which can be used with this invention to measure the change of cytochrome c that occurs. Also, ferrocene or ferrocene derivatives have been used as electron acceptors for electrochemical methods as reported in the US Patent No. 4,545,382.
- acceptors can also be used in the present enzymatic theophylline measurement and the change measured electrochemically.
- the change of ferricyanide to ferrocyanide can be determined by measuring the change in current using platinum electodes as has been established and reported in Anal Chem 36, 343 (1964).
- NADPH is shown as electron donor.
- NADH electron donor
- FADH electron donor
- the formaldehyde reaction product can be measured by customary and already known chemical, enzymatic, or electrochemical methods.
- Example 5 shows one method of measuring formaldehyde when the theophylline enzyme T-040 was used. As indicated in the Example, the formaldehyde thus produced was proportionate to the concentration of theophylline in the sample.
- reaction products xanthine or methyl xanthine can also be measured as indicated below:
- the hydrogen peroxide (H-2O2) formed can be measured by various methods as mentioned earlier, while uric acid or methyl uric acid can be measured, for example, by determining the increase in absorbance at 292 nm wavelength or colorimetrically as described in Clin Chem 26, 227 (1980).
- the decrease of NADPH or NADH can also be measured spectrophotometrically or fluorometrically by customary methods as described in Anal Biochem 12, 357 (1965).
- the decrease of FADH can be measured by measuring the decrease at 450 nm wavelength as shown in J Biol Chem 246, 2371 (1971).
- other products produced by the enzymatic recognition of theophylline and measured by customary methods such as spectrophotometric, electrochemical or chrom tographic or alternatively by a decrease in theophylline concentration as in Example 1.
- test reagent compositions and devices of the present invention can contain state of the art additives and adjuvants which are advantageous to the reaction, such as, for example, buffers, suspending agents, thickening agents, color enhancers, surfactants, and so forth.
- compositions of the present invention can advantageously be incorporated into solid carriers or matrices.
- Such a configuration or format is referred to in the art as dry-chemistry or solid state test device formats.
- the most common matrix is paper; however, other bibulous materials such as polymers, clays, gels and so forth may be utilized.
- the reagent composition is incorporated or impregnated into the matrix and dried. In use, the device is either dipped into or contacted with the sample being tested.
- the signal generated in the device by the reaction of theophylline with the test composition containing inr.o-r alia the theophylline utilizing enzyme can then be detected and quantified using state of the art techniques, such as, for example, visual comparison to a color chart, reflectance spectrophotometry, and so forth.
- Example 10 shows the device resulting from impregnating a filter paper with the theophylline enzyme T-090 and cytochrome c.
- the change in color with increasing concentration of theophylline can be read semi-quantitatively by visual inspection or quantitatively by existing reflectance measuring instruments. Alternatively, the change in electron transfer in a solid matrix can be measured electrochemically.
- the enzyme activity is defined as 1 ⁇ mole of theophylline utilized per minute at 30° C. temperature.
- the assay mixture contained 0.05 M potassium phosphate buffer pH 7.0 and 0.4 u/ml of the theophylline enzyme T-060.
- 100 ⁇ l of a sample containing theophylline at several concentrations was added in separate cuvettes.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C. A decrease in optical density at 272 n was observed after 30 minutes which was proportionate to the theophylline concentration in the sample.
- Theophylline concentration Decrease in OD at 272 nm
- the assay mixture contained 50 ⁇ moles/ml potassium phosphate buffer at pH 7.5 and 1.8 u/ml of the theophylline enzyme T-090 and 25 nmoles/ml of cytochrome c.
- 25 ⁇ l of a sample containing theophylline at the following concentrations were added in separate cuvettes.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C. After 20 minutes, the decrease in optical density at 272 nm was recorded which was proportionate to the theophylline concentration in the sample.
- the theophylline enzyme T-090 was used.
- Curve A describes the absorbance spectra of the theophylline enzyme T-090 at a concentration of 1.8 u/ml in 0.05 M potassium phosphate buffer at pH 7.5.
- Curve B shows the absorbance spectra of the same enzyme in the presence of theophylline at the concentration of 2 mg/L under the same conditions.
- theophylline caused the increase in absorbance at 417.5 and 550 nm wavelength. These changes in absorptions are used as a basis for the determination of theophylline concentration in a sample.
- the theophylline enzyme T-090 was used with potassium ferricyanide as an acceptor.
- the potassium ferricyanide changed to ferrocyanide in the presence of the enzyme when theophylline was added.
- the formation of ferrocyanide can be measured by measuring the decrease in optical density at 410 nm.
- the assay mixture contained 50 ⁇ moles/ml of potassium phosphate buffer, 1.8 u/ml of theophylline enzyme, and 1.43 ⁇ moles/ml of potassium ferricyanide.
- 50 ⁇ l of a sample containing theophylline at the following concentrations was added in separate cuvettes.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C. After 30 minutes, the decrease in optical density at 410 nm wavelength was measured which was proportionate to the concentration of theophylline in the sample.
- the theophylline enzyme T-040 was used. In the presence of NADPH or NADH, this enzyme de ethylated theophylline and produced xanthine and/or 1 and/or 3 methyl xanthine and formaldehyde.
- the formaldehyde was measured by a known chemical method as reported by Nash, Bioche J 55, 416-421 (1953). The formaldehyde production was proportionate to the concentration of theophylline in the sample.
- the assay mixture contained 50 ⁇ moles/ml of Tris-HCL buffer pH 8.0, 1 ⁇ mole/ml of NADPH and 10 nmoles/ml of semicarbazide.
- the theophylline enzyme T-060 was used which produced 1,3 dimethyl uric acid and hydrogen peroxide in the presence of theophylline.
- the hydrogen peroxide was thus measured by a known modified Trinder's method as described by Fossati et al., Clin Chem 26, 227 (1980).
- the assay mixture contained 50 ⁇ moles/ml potassium phosphate, pH 7.5, 5 ⁇ moles/ml of 3,5-dichloro-2-hydroxy benzene sulfonate hydrochloride (DHBS), 1 ⁇ mole/ml 4-aminoantipyrine, 5.0 u/ml of horseradish peroxidase and 0.7 u/ml of the theophylline enzyme T-060.
- DHBS 3,5-dichloro-2-hydroxy benzene sulfonate hydrochloride
- 4-aminoantipyrine 5.0 u/ml of horseradish peroxidase
- 0.7 u/ml of the theophylline enzyme T-060 To 0.7 ml assay mixture, 50 ⁇ l of a sample containing theophylline at the following concentrations was added in separate cuvettes. The reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 37° C. After
- the theophylline enzyme T-090 was used with cytochrome c. In the presence of theophylline the reaction produced 1,3 dimethyl uric acid. This product was measured at 292 nm which is the wavelength of maximum absorbance for 1,3 dimethyl uric acid.
- the assay mixture contained 50 ⁇ moles/ml potassium phosphate buffer at pH 7.5 , 1.8 u/ml of the theophylline enzyme T-090 and 25 nmoles/ml of cytochrome c.
- 25 ⁇ l of a sample containing theophylline at the following concentrations was added in separate cuvettes.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C. After 20 minutes, the increase in optical density at 292 nm was recorded which was proportionate to the theophylline concentration in the sample.
- the theophylline enzyme T-090 was used with potassium ferricyanide as an acceptor which produces potassium ferrocyanide in the presence of theophylline.
- the ferrocyanide thus produced is measured chemically by using 4,7 diphenyl-1,10 phenanthroline sulfonate as described by Avon and Shavit in Anal Biochem 6, 549 (1963).
- the assay mixture contained 50 ⁇ moles/ml of potassium phosphate buffer at pH 7.5, 1.8 u/ml of the theophylline enzyme T-090, and 1.43 ⁇ moles/ml of potassium ferricyanide.
- 50 ⁇ l of a sample containing theophylline at the following concentrations was added.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C for 30 minutes. From the above, 50 ⁇ l of assay mixture was mixed with 35 ⁇ l of deionized water and 150 ⁇ l of color producing reagent.
- the color producing reagent contains 1 M sodium acetate, 0.066 M citric acid, .00055 M ferrichloride in 0.1 M acetic acid, and 83.3 ⁇ g of 4,7-diphenyl-l,10 phenanthroline. After 6 minutes the absorbance was measured at 535 nm wavelength. The absorbance is proportionate to the concentration of theophylline.
- the theophylline enzyme T-090 was used with ferricytochrome c as an acceptor which produces 1,3 dimethyl uric acid and ferrocytochrome c in the presence of theophylline.
- the formation of ferrocytochrome c is measured by the increase in absorbance at 550 nm wavelength.
- the assay mixture contained 50 ⁇ moles/ml of potassiom phosphate buffer at pH 7.5, 5 u/ml of the theophylline enzyme T-090, and 0.25 nmoles/ml horse ferricytochrome c.
- 25 ⁇ l of sample containing theophylline at the following concentrations was added in separate cuvettes.
- the reaction was carried out in a Gilford spectrophotometer with 10 mm light path cuvette at 30° C. After 15 minutes, when the reaction was complete, the increase in optical density was measured.
- the absorbance has a linear relationship to the concentration of theophylline in the sample.
- Ten by ten mm square filter paper was impregnated with a solution containing the theophylline enzyme T-090 at various concentrations.
- a solution containing the theophylline enzyme T-090 for example, 50 u of the theophylline enzyme T-090 in 0.05 M phosphate buffer, pH 7.5. This solution also contained 1 ⁇ mole/ml of ferricytochrome c.
- the paper was dipped in the above solution and air dried.
- 50 ⁇ l of serum containing different concentrations of theophylline, 5-40 mg/L was added to the filter paper, increasingly deeper shades of pink appeared corresponding to the increasing theophylline concentration. The gradation of pink color allowed the estimation of the different theophylline concentrations.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention décrit une nouvelle méthodologie et une nouvelle composition d'essai pour déterminer la présence de théophylline dans des échantillons d'essai. Cette méthodologie fait appel à des enzymes qui mettent en oeuvre ou reconnaissent la théophylline sous forme d'un substrat pour mesurer la concentration de cette dernière dans des échantillons, y compris des fluides corporels. Cette nouvelle approche fait appel à des enzymes par opposition aux méthodes classiques utilisant des anticorps pour reconnaître la théophylline. Cette méthode enzymatique de dosage de la théophylline est rapide, simple et commode et permet de réaliser des systèmes d'essai dans des formats de chimie par voie liquide ainsi que par voie sèche. On peut utiliser divers protocoles, systèmes ou méthodologies pour effectuer des analyses et rappporter les résultats à la quantité de théophylline présente.The present invention describes a new methodology and test composition for determining the presence of theophylline in test samples. This methodology uses enzymes that use or recognize theophylline as a substrate to measure the concentration of theophylline in samples, including body fluids. This new approach uses enzymes as opposed to conventional methods using antibodies to recognize theophylline. This enzymatic method for assaying theophylline is quick, simple and convenient and allows test systems to be performed in liquid and dry chemical formats. Various protocols, systems or methodologies can be used to perform analyzes and relate the results to the amount of theophylline present.
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15549888A | 1988-02-12 | 1988-02-12 | |
US155498 | 1988-02-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0402373A1 true EP0402373A1 (en) | 1990-12-19 |
EP0402373A4 EP0402373A4 (en) | 1991-01-30 |
Family
ID=22555682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19890902593 Withdrawn EP0402373A4 (en) | 1988-02-12 | 1989-02-07 | Enzymatic determination of theophylline |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0402373A4 (en) |
JP (1) | JPH03503121A (en) |
AU (1) | AU3063689A (en) |
FI (1) | FI903958A0 (en) |
WO (1) | WO1989007653A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU626724B2 (en) * | 1988-02-12 | 1992-08-06 | Gds Technology, Inc. | Enzymatic determination of theophylline |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6029473B2 (en) * | 1977-10-04 | 1985-07-10 | 東洋醸造株式会社 | Process for producing sarcosine oxidase |
US4235869A (en) * | 1978-05-16 | 1980-11-25 | Syva Company | Assay employing a labeled Fab-fragment ligand complex |
US4341868A (en) * | 1978-08-18 | 1982-07-27 | Kyowa Hakko Kogyo Co., Ltd. | Method and test composition for the determination of the substrate for xanthine oxidase |
AU590883B2 (en) * | 1985-05-28 | 1989-11-23 | Nippon Kayaku Kabushiki Kaisha | Method of quantitative assay for 1,5-anhydroglucitol |
-
1989
- 1989-02-07 AU AU30636/89A patent/AU3063689A/en not_active Abandoned
- 1989-02-07 JP JP50240989A patent/JPH03503121A/en active Pending
- 1989-02-07 WO PCT/US1989/000485 patent/WO1989007653A1/en not_active Application Discontinuation
- 1989-02-07 EP EP19890902593 patent/EP0402373A4/en not_active Withdrawn
-
1990
- 1990-08-10 FI FI903958A patent/FI903958A0/en not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO8907653A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0402373A4 (en) | 1991-01-30 |
WO1989007653A1 (en) | 1989-08-24 |
AU3063689A (en) | 1989-09-06 |
JPH03503121A (en) | 1991-07-18 |
FI903958A0 (en) | 1990-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fossati et al. | Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. | |
US5126247A (en) | Method, system and devices for the assay and detection of biochemical molecules | |
US5094943A (en) | Process and reagent for the improved quantitative colorimetic determination of hydrogen peroxide | |
JPH0687793B2 (en) | Method and reagent for colorimetric determination of analyte by enzymatic oxidation, and reductive chromogenic electron acceptor therefor | |
EP0029104B1 (en) | A composition, test device and method of making it, and method for the determination of an analyte in a liquid | |
JP2003232789A (en) | Stabilized tetrazolium dye reagent composition and method for use thereof | |
JPS5948099A (en) | Glucose test composition for ascorbate resistant wide concentration region, test tool and method | |
US4215197A (en) | Test means and method for creatinine determination | |
Kohlbecker et al. | Direct spectrophotometric determination of serum and urinary oxalate with oxalate oxidase | |
MX2007002224A (en) | Method for determining the concentration of analytes in samples by direct mediation of enzymes. | |
US4394444A (en) | Cofactor indicator compositions | |
JP2796150B2 (en) | How to measure fructosamine | |
US5188941A (en) | Enzymatic determination of theophylline | |
EP0402373A1 (en) | Enzymatic determination of theophylline | |
CA1339794C (en) | Enzymatic determination of theophylline | |
JP3710166B2 (en) | Method for measuring D-sorbitol and kit for measuring the same | |
JPS5818077B2 (en) | Method and reagent for measuring glycerin | |
JP4217815B2 (en) | Method for quantifying glucose by glucose dehydrogenase and reagent for quantifying glucose | |
IWAI et al. | Electric microassays of glucose, uric acid and cholesterol using peroxidase adsorbed on a carbon electrode | |
Kayamori et al. | Enzymatic method for assaying uric acid in serum with a new tetrazolium salt produces water-soluble formazan dye | |
AU626724B2 (en) | Enzymatic determination of theophylline | |
CA1206077A (en) | Sensitive enzymatic creatinine assay | |
JP2001078797A (en) | Reagent for eliminating glucose and/or glucono-1,5- lactone | |
JPS60210998A (en) | Test composition, test kit and method for enzymatical measurement of inorganic phosphate | |
US5487978A (en) | Method, composition and device for the determination of cholesterol using cholesterol oxidase obtained from bacterial strain NRRL B-18713 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19900810 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: GUPTA, SURENDRA, KUMAR Inventor name: AGARWAL, ARUN, KUMAR Inventor name: DECASTRO, AURORA, FERNANDEZ |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19901212 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
111Z | Information provided on other rights and legal means of execution |
Free format text: AT BE CH DE FR GB IT LI LU NL SE |
|
17Q | First examination report despatched |
Effective date: 19930305 |
|
R11X | Information provided on other rights and legal means of execution (corrected) |
Free format text: AT BE CH DE FR GB IT LI LU NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19950317 |